Bacteremia and Infective Endocarditis Caused by a Non-Daptomycin-Susceptible, Vancomycin-Intermediate, and Methicillin-Resistant Staphylococcus aureus Strain in Taiwan | Zendy

YuTsung Huang | Zendy; ChihTing Lin | Zendy; ChunHsing Liao | Zendy; ChungWei Lee | Zendy; PoRen Hsueh | Zendy

Open Access

Bacteremia and Infective Endocarditis Caused by a Non-Daptomycin-Susceptible, Vancomycin-Intermediate, and Methicillin-Resistant Staphylococcus aureus Strain in Taiwan

Author(s) -

YuTsung Huang,

ChihTing Lin,

ChunHsing Liao,

ChungWei Lee,

PoRen Hsueh

Publication year - 2008

Publication title -

journal of clinical microbiology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.349

H-Index - 255

eISSN - 1070-633X

pISSN - 0095-1137

DOI - 10.1128/jcm.01844-07

Subject(s) - daptomycin , bacteremia , linezolid , vancomycin , staphylococcus aureus , medicine , infective endocarditis , endocarditis , microbiology and biotechnology , staphylococcal infections , fusidic acid , methicillin resistant staphylococcus aureus , glycopeptide antibiotic , glycopeptide , antibiotics , surgery , biology , bacteria , genetics

We describe the development of nonsusceptibility to daptomycin and vancomycin during treatment for methicillin-resistant Staphylococcus aureus (MRSA) bacteremia associated with infective endocarditis and probable septic thrombophlebitis in a uremic patient. MRSA bacteremia persisted during glycopeptide and subsequent daptomycin treatment but cleared after 5 days' treatment with linezolid and fusidic acid.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research